Takeda's R&D park is accepting membership applications for Japan VC Consortium, a life sciences-focused venture capital and corporate venturing engagement centre.

Shonan Health Innovation Park (Shonan iPark), the research and development (R&D) facility operated by Japan-based pharmaceutical firm Takeda, launched a venture capital cooperative venue yesterday. Japan VC Consortium aims to accelerate Japan’s biotechnology and life sciences-themed VC and corporate venturing investments. It has opened the application period for the initial batch of 20 companies, which…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.